Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Metadata
Title
New Strategies in Chronic Myeloid Leukemia
Authors
Hagop M. Kantarjian
Jorge Cortes
Publication date
01-05-2006
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2006
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.06024

Other articles of this Issue 4/2006

International Journal of Hematology 4/2006 Go to the issue

Progress in Hematology

New Therapeutic Approach for Myeloid Leukemia: Induction of Apoptosis via Modulation of Reactive Oxygen Species Production by Natural Compounds

Letter to the Editor

Methotrexate-Associated Lymphoproliferative Disorder Mimicking Composite Lymphoma

Case Report

CD7/CD19 Double-Positive T-Cell Acute Lymphoblastic Leukemia

Case Report

Antibody Responses Associated with the Graft-versus-Leukemia Effect in Adult T-Cell Leukemia

Progress in Hematology

The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors

Case Report

Early-Onset Thyrotoxicosis after Unrelated Cord Blood Transplantation for Acute Myelogenous Leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits